Not Tagged
ashvattha therapeutics
[]
ashvattha therapeutics presented promising preclinical data on novel macrophage switching nanomedicine d-4559 at aacr annual meeting - demonstrated d-4559 switches tumor associated macrophages from an m2 to m1 pro-inflammatory phenotype leading to reduc... 
CEO Of Digital Media Online